Abstract

BackgroundApproximately 70 million people in the United States have hypertension. Although antihypertensive therapy can reduce the morbidity and mortality associated with hypertension, often patients do not take their medication as prescribed.ObjectiveThe goal of this study was to better understand issues affecting the acceptability and usability of mobile health technology (mHealth) to improve medication adherence for elderly African American and Native Hawaiian and Pacific Islander patients with hypertension.MethodsIn-depth interviews were conducted with 20 gatekeeper-stakeholders using targeted open-ended questions. Interviews were deidentified, transcribed, organized, and coded manually by two independent coders. Analysis of patient interviews used largely a deductive approach because the targeted open-ended interview questions were designed to explore issues specific to the design and acceptability of a mHealth intervention for seniors.ResultsA number of similar themes regarding elements of a successful intervention emerged from our two groups of African American and Native Hawaiian and Pacific Islander gatekeeper-stakeholders. First was the need to teach participants both about the importance of adherence to antihypertensive medications. Second, was the use of mobile phones for messaging and patients need to be able to access ongoing technical support. Third, messaging needs to be short and simple, but personalized, and to come from someone the participant trusts and with whom they have a connection. There were some differences between groups. For instance, there was a strong sentiment among the African American group that the church be involved and that the intervention begin with group workshops, whereas the Native Hawaiian and Pacific Islander group seemed to believe that the teaching could occur on a one-to-one basis with the health care provider.ConclusionsInformation from our gatekeeper-stakeholder (key informant) interviews suggests that the design of a mHealth intervention to improve adherence to antihypertensives among the elderly could be very similar for African Americans and Native Hawaiian and Pacific Islanders. The main difference might be in the way in which the program is initiated (possibly through church-based workshops for African Americans and by individual providers for Native Hawaiian and Pacific Islanders). Another difference might be who sends the messages with African Americans wanting someone outside the health care system, but Native Hawaiian and Pacific Islanders preferring a provider.

Highlights

  • Hypertension is the most common condition seen in primary care and may lead to myocardial infarction, stroke, renal failure, and death if not treated appropriately

  • Information from our gatekeeper-stakeholder interviews suggests that the design of a mobile health technology (mHealth) intervention to improve adherence to antihypertensives among the elderly could be very similar for African Americans and Native Hawaiian and Pacific Islanders

  • The main difference might be in the way in which the program is initiated

Read more

Summary

Introduction

Hypertension is the most common condition seen in primary care and may lead to myocardial infarction, stroke, renal failure, and death if not treated appropriately. In 2011, the cost burden in the United States associated with hypertension was estimated at US $46 billion in health care services, medications, and missed days of work [1]. Racial and ethnic minority populations bear a disproportionate burden of hypertension and its sequelae. Estimates from the National Health Interview Survey in 2007 found that Native Hawaiians and Pacific Islanders had the second highest rates of any ethnic group in the United States at 29% [2,3,4,5]. Despite evidence that appropriate pharmacological treatment reduces morbidity and mortality across all populations [6,7,8], racial and ethnic minorities, including African Americans and Native Hawaiian and Pacific Islanders, often underutilize antihypertensive medications [9,10,11]. Antihypertensive therapy can reduce the morbidity and mortality associated with hypertension, often patients do not take their medication as prescribed

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.